A C. diff (Clostridioides difficile) diet may help alleviate diarrhea (the primary symptom) that is associated with this bacterial infection. Clostridioides difficile (previously known as ...
The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...
EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections ...
EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections ...
Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal ...
Learn about VE303, a potential first-in-class Live Biotherapeutic Product for preventing recurrent Clostridioides difficile ...
Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...
LPOXY’s plan is to take Sidiprev into a phase 2 study in hospitalized patients with Clostridioides difficile infection. Known as one of the superbugs that resists most antibiotics, C.